The Data Compilation Core (Core B) will develop and maintain a central resource of analysis-ready, annotated and documented data sets from clinical trials and related studies to be utilized by the investigators of the program. These data sets will be used to evaluate the methods developed in this program as well as to demonstrate the software developed in the Computational Resource Core (Core C). The primary source of the data will be the clinical trials and related studies of the Cancer and Leukemia Group B (CALGB), one of the major NCI-sponsored cancer cooperative groups. In addition, data from cancer research studies conducted at two large NCI-designated Comprehensive Cancer Centers, the Lineberger Comprehensive Cancer Center at UNC and the Duke Comprehensive Cancer Center, will also be utilized. This is a major advantage for the program in that the data sets provided can be exceptionally well annotated and documented, with the direct involvement of clinical and statistical scientists who were involved in the primary design and analysis of the studies.
A major disadvantage of using public data sets is that the investigator is often unable to understand the clinical and molecular data as the data are provided without appropriate documentation. Indeed, it is not possible to carry out a thorough statistical analysis of data from clinical trials without taking into account and understanding the design of the study, the specifics of the data collection process, the history of the study and the medical issues. This core will address these issues by providing analysis-ready data sets with extensive annotation and documentation.
|Innocenti, Federico; Jiang, Chen; Sibley, Alexander B et al. (2018) Genetic variation determines VEGF-A plasma levels in cancer patients. Sci Rep 8:16332|
|Zhao, Junlong; Yu, Guan; Liu, Yufeng (2018) ASSESSING ROBUSTNESS OF CLASSIFICATION USING ANGULAR BREAKDOWN POINT. Ann Stat 46:3362-3389|
|Gao, Fei; Zeng, Donglin; Lin, Dan-Yu (2018) Semiparametric regression analysis of interval-censored data with informative dropout. Biometrics :|
|Li, Hao; Chen, Ming-Hui; Ibrahim, Joseph G et al. (2018) Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs. Biostatistics :|
|Wang, Ting; Wang, Xiaofei; Zhou, Haibo et al. (2018) Auxiliary variable-enriched biomarker-stratified design. Stat Med 37:4610-4635|
|Potthoff, Richard F (2018) Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation results. J Biopharm Stat 28:633-644|
|Hibbard, Jonathan C; Friedstat, Jonathan S; Thomas, Sonia M et al. (2018) LIBERTI: A SMART study in plastic surgery. Clin Trials 15:286-293|
|Burbank, Allison J; Todoric, Krista; Steele, Pamela et al. (2018) Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics. Respir Res 19:152|
|Urrutia, Eugene; Chen, Hao; Zhou, Zilu et al. (2018) Integrative pipeline for profiling DNA copy number and inferring tumor phylogeny. Bioinformatics 34:2126-2128|
|Chen, Jingxiang; Fu, Haoda; He, Xuanyao et al. (2018) Estimating individualized treatment rules for ordinal treatments. Biometrics 74:924-933|
Showing the most recent 10 out of 549 publications